Brief: Deciphera Pharmaceuticals Reports Q4 product revenues $32.88 million
07/02/2023 12:12
Feb 7 (Reuters) - Deciphera Pharmaceuticals: * Q4 operating expenses USD 83.506 million. * Q4 product revenues USD 32.88 million * Q4 net income USD -45.934 million
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions